LI
Liminatus Pharma, Inc. Warrants
LIMNW · NASDAQ
$0.05 +0.00% (+$0.00)
1M -13.48%
Market Cap $1.31M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
46 /100
Fair P/B 4.36x
PEG N/A
P/E N/A
Growth
-
N/A FCF growth N/A
EPS growth N/A
Book val. growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor Asset turnover 0.00x
ROIC 225.12%
ROA 367.93%
Debt
10 /100
High Int. coverage -164.56x
Debt/Equity 4.80x
Current ratio 1.12x
Stability
37 /100
Moderate Profitable years 0
Beta 0.74x
EPS volatility 79.63%
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre LIMNW
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Chris Kim
Employees
1
Headquarters
Cerritos